home / stock / canf / canf quote
Last: | $1.49 |
---|---|
Change Percent: | 0.7% |
Open: | $1.41 |
Close: | $1.49 |
High: | $1.5 |
Low: | $1.4 |
Volume: | 41,898 |
Last Trade Date Time: | 02/12/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.49 | $1.41 | $1.49 | $1.5 | $1.4 | 41,898 | 02-12-2025 |
$1.42 | $1.42 | $1.42 | $1.45 | $1.38 | 49,973 | 02-11-2025 |
$1.38 | $1.43 | $1.38 | $1.4699 | $1.37 | 124,192 | 02-10-2025 |
$1.37 | $1.42 | $1.37 | $1.4838 | $1.35 | 60,508 | 02-07-2025 |
$1.42 | $1.47 | $1.42 | $1.48 | $1.4061 | 41,401 | 02-06-2025 |
$1.47 | $1.45 | $1.47 | $1.4954 | $1.44 | 88,520 | 02-05-2025 |
$1.39 | $1.45 | $1.39 | $1.49 | $1.38 | 140,812 | 02-04-2025 |
$1.46 | $1.48 | $1.46 | $1.4839 | $1.43 | 56,648 | 02-03-2025 |
$1.48 | $1.5144 | $1.48 | $1.5499 | $1.46 | 73,509 | 01-31-2025 |
$1.55 | $1.53 | $1.55 | $1.5664 | $1.51 | 44,954 | 01-30-2025 |
$1.53 | $1.58 | $1.53 | $1.59 | $1.5201 | 51,509 | 01-29-2025 |
$1.56 | $1.56 | $1.56 | $1.61 | $1.53 | 48,751 | 01-28-2025 |
$1.56 | $1.55 | $1.56 | $1.6 | $1.5 | 393,155 | 01-27-2025 |
$1.56 | $1.55 | $1.56 | $1.6 | $1.4924 | 69,659 | 01-24-2025 |
$1.53 | $1.52 | $1.53 | $1.5599 | $1.45 | 109,060 | 01-23-2025 |
$1.54 | $1.56 | $1.54 | $1.59 | $1.49 | 70,805 | 01-22-2025 |
$1.58 | $1.55 | $1.58 | $1.64 | $1.53 | 79,266 | 01-21-2025 |
$1.55 | $1.57 | $1.55 | $1.5999 | $1.53 | 78,866 | 01-20-2025 |
$1.55 | $1.57 | $1.55 | $1.5999 | $1.53 | 78,866 | 01-17-2025 |
$1.59 | $1.56 | $1.59 | $1.6399 | $1.56 | 59,793 | 01-16-2025 |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite Biopharma Ltd Sponsored ADR Website:
Can-Fite’s data will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium Can-Fite enrolls patients for its pivotal Phase III advanced liver cancer study Ramat Gan, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF...
RAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announced today that a patient currently treated wi...
ORLANDO, FL / ACCESSWIRE / November 22, 2024 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Can-Fite BioPharma Ltd. (NYSE American:CANF)(TASE:CANF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Sa...